Finally, hydroxychloroquine that interferes with NETs formation through inhibition of TLR9 has been proposed as a therapeutical intervention for COVID-19, although it has already been shown that it does not improve clinical outcome and mortality of patients with COVID-19 (130, 131). The gene discussed is TLR9; the disease is COVID-19.